SEC Contract Filing

Filing Date: 2023-12-26

Document Content:
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>exhibit_10-3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<html>
 <head>
 <title></title>
 <!-- Licensed to: ZKG
 Document created using Broadridge PROfile 23.12.1.5186
 Copyright 1995 - 2023 Broadridge -->
 </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
 <div>
 <div class="BRPFPageHeader">
 <div style="line-height: 1.25;">
 <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
 </div>
 <div style="line-height: 1.25; text-align: right;"><u><font style="font-weight: bold;">Exhibit 10.3</font></u><br style="line-height: 1.25;">
 </div>
 <div style="line-height: 1.25">&#160;</div>
 <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
 COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.&#160; THIS
 SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</div>
 <div style="line-height: 1.25;"><br style="line-height: 1.25;">
 </div>
 <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">ORDINARY SHARE PURCHASE WARRANT</div>
 <div style="line-height: 1.25;"><br style="line-height: 1.25;">
 </div>
 <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">ENTERA BIO LTD.</div>
 <div style="line-height: 1.25">&#160;
 <div style="line-height: 1.25">
 <table cellspacing="0" cellpadding="0" border="0" id="z4d857671719041b087a3b4ea9ea5265c" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

 <tr>
 <td style="width: 70%;">
 <div>
 <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Warrant Shares: [&#8226;]</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
 </div>
 </td>
 <td style="width: 30%;">
 <div>&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Issue Date: [<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#8226;</font>], 2023</font></div>
 </td>
 </tr>

 </table>
 </div>
 </div>
 <div style="line-height: 1.25">&#160;</div>
 <div style="text-align: justify; text-indent: 72pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">THIS ORDINARY SHARE PURCHASE WARRANT (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Warrant</u></font>&#8221;) certifies that, for value received, [HOLDER] or its assigns (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Holder</u></font>&#8221;) is entitled, upon the terms and subject to the
 limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Initial Exercise Date</u></font>&#8221;) and on or prior to 5:00
 p.m. (New York City time) on [<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#8226;</font>], 2028 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Termination Date</u></font>&#8221;) but not
 thereafter, to subscribe for and purchase from Entera Bio Ltd., a company organized under the laws of the State of Israel (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Company</u></font>&#8221;), up to [<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#8226;</font>]&#160; Ordinary Shares (as subject to adjustment hereunder, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Warrant Shares</u></font>&#8221;).&#160;

 The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).&#160; The Warrant is being issued pursuant to that certain Securities Purchase Agreement, dated November 20, 2023, among the
 Company and the purchasers signatory thereto, as amended and/or restated from time to time (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Purchase Agreement</u></font>&#8221;).</div>
 <div style="line-height: 1.25">&#160;</div>
 <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 1</u>.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Definitions</u></font>.&#160; Capitalized terms used and not otherwise defined herein shall have the meanings set forth in the Purchase Agreement.</font></div>
 <div style="line-height: 1.25">&#160;</div>
 <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roma